PTA-Adhoc: Dr. Hönle AG: Declining market for air sterilization devices leads to impairment of inventories at Hönle
Public disclosure of inside information according to article 17 MAR
Gilching (pta026/02.12.2022/15:35) - The corona pandemic led to massive demand for mobile air purification devices that were used to reduce the germ load and control the risk of infection. The use of mobile air cleaning devices in public education and training facilities was also significantly encouraged by the grant of funding measures. In order to be able to participate in this market on a large scale, Dr. Hönle AG produced air sterilization devices in large numbers.
With the gradual reduction in corona restrictions, the demand for mobile air disinfection devices also decreased significantly. Even through the use of targeted marketing measures, sales can only be increased insignificantly. Due to sales risks, Dr. Hönle AG therefore makes adjustments of around 60% of its inventory of air disinfection devices in the 2021/2022 financial year, which corresponds to a value of EUR 6.4 million.
As already published in the notification of November 2, 2022, restructuring measures were also initiated at Raesch Quartz (Germany) GmbH, which resulted in one-off special effects in the 2021/2022 financial year. Dr. Hönle AG is currently examining various options for implementing the restructuring measures initiated at Raesch Quartz (Germany) GmbH. The individual restructuring measures have a retrospective effect on several items and disclosures in the 2021/2022 annual financial statements.
Due to the special effects mentioned above the Management Board therefore anticipates an operating result (EBIT) of EUR -9.5 million to EUR -11.0 million for the Hönle Group in the 2021/2022 financial year. In its last report, the Management Board expected an operating result (EBIT) of EUR -3.0 million to EUR -3.5 million.
Without the one-off special effects, the Hönle Group will probably achieve the communicated operating result target of EUR 9 million to EUR 11 million.
With an estimated EUR 127 million, sales in the 2021/2022 financial year will reach the announced sales target of EUR 125 million to EUR 130 million.
The review and implementation of the options for the restructuring measures at Raesch Quartz (Germany) GmbH and their effects on the 2021/2022 annual financial statements will be finalized by mid-December 2022. The publication of the preliminary figures for the financial year will therefore be postponed from December 8, 2022 to December 21, 2022.
Dr. Hönle AG is a listed technology company headquartered in Gilching, Germany. With its nearly 700 employees, the Hönle Group develops innovative solutions for a wide variety of industrial manufacturing processes. One focus of its activities is the development and sale of industrial adhesives and casting compounds. Moreover, the company manufactures equipment for ink and paint drying, adhesives and plastic curing as well as for air, water and surface disinfection and sunlight simulation. In addition, the corporate group produces UV lamps for disinfection and drying processes, among others, and manufactures tubes and semi-finished products made of quartz glass for use in various branches of industry. The Hönle Group supplies technology and world market leaders worldwide and is represented by its own entities and partner companies in more than 20 countries.
emitter: Dr. Hönle AG
address: Nicolaus-Otto-Str. 2, 82205 Gilching
contact person: Peter Weinert
phone: +49 8105 2083 173
ISIN(s): DE0005157101 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate